Funded Startups in Markham
Across the 22 most recent Markham rounds shown, the largest disclosed amount is Edesa Biotech’s $11M (2025-02-13).
Across the 22 most recent Markham rounds shown, the largest disclosed amount is Edesa Biotech’s $11M (2025-02-13). That figure dwarfs the next-largest disclosed amount of $5M (ventureLAB on 2024-01-16), with most other disclosed rounds clustering below $4M; the next-highest disclosed amounts are $3M (Invixium, 2020-06-08) and $2M (Innovere Medical, 2020-12-21). The data also shows a sector pattern: biotechnology appears in 3 entries (Edesa Biotech in 2025, Memory & Company in 2024, and Canntab Therapeutics/Invixium in 2022/2020), while “Series Unknown” covers a majority of the list (11 of 22 rows), with “undisclosed” amounts appearing 5 times.
Temporally, the visible rounds span 2020-06-08 to 2025-02-13, and there is a tighter concentration in 2022–2023 (multiple rounds on 2022-12-16: Cyberworks Robotics, MapleWiz Solutions, and Tasteport, each at $10K). Stage signals are mixed: named stages appear on a smaller subset (e.g., Seed at Javelin Sports, $1M on 2023-04-05; Grant at Adastra, $1M on 2022-08-22; Post-IPO Equity at VIQ Solutions and Pond Technologies at $5M and $1M on 2022-07-19 and 2022-09-06).
Most recent rounds
22 shownRelated listings
Frequently asked
What’s the largest disclosed round in Markham in this list, and how does it compare to the rest of the disclosed amounts?
Edesa Biotech’s $11M disclosed round (2025-02-13) is the only disclosed amount above $5M in the table. The next-largest disclosed round is $5M (ventureLAB, 2024-01-16), while most other disclosed amounts sit at $4M or below (e.g., Exact Imaging $4M on 2021-03-23; Innovere Medical $2M on 2020-12-21).
Which sectors are over-represented across these 22 Markham entries?
Biotechnology is the clearest cluster with 3 entries: Edesa Biotech (2025-02-13, $11M), Memory & Company (2024-05-09, undisclosed), and Canntab Therapeutics plus Invixium (2022-02-01, $1M; 2020-06-08, $3M). AI appears in 2 entries (Adastra, 2022-08-22, $1M; VIQ Solutions, 2022-07-19, $5M), while several other sectors show up once or twice.
Do most rounds have the same stage classification, or is there a stage mix?
“Series Unknown” is the dominant label at 11 of 22 rows, and “Grant”/“Seed”/“Post-IPO” appear in smaller pockets (e.g., Javelin Sports Seed, $1M on 2023-04-05; Adastra Grant, $1M on 2022-08-22; VIQ Solutions Post-IPO Equity, $5M on 2022-07-19). Named stages therefore concentrate on a minority of entries rather than providing a uniform pattern.
Are there time clusters in the most recent Markham funding rounds shown?
Yes. The table includes a notable 2022-12-16 cluster with three $10K rounds: Cyberworks Robotics, MapleWiz Solutions, and Tasteport. More broadly, the visible window runs from 2020-06-08 (Invixium) to 2025-02-13 (Edesa Biotech), with multiple rounds also occurring in 2022–2023 (e.g., Canntab Therapeutics on 2022-02-01; several entries spanning 2022-07 to 2022-09).
Are there amount outliers driven by disclosure status or unusually low disclosed amounts?
In disclosure terms, “undisclosed” amounts appear 5 times (e.g., Logic Tech on 2024-10-02 and Memory & Company on 2024-05-09), so some comparisons are constrained to disclosed rounds. Among disclosed amounts, the low end is repeatedly $10K (Remix Snacks is $10K on 2025-02-05; Cyberworks Robotics/MapleWiz Solutions/Tasteport are each $10K on 2022-12-16), while the high end is set by Edesa Biotech’s $11M (2025-02-13).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.